Heparin- induced thrombocytopenia (HIT): a case report of CABG patient

authors:

avatar alireza jahangirifard 1 , * , avatar Majid Golestani Eraghi 2 , avatar Mohammad Ali Saghafi 3

Assistant Professor of Anesthesiology, Fellowship of Cardiac Anesthesia, Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran
Anesthesiologist, Fellowship in intensive care, Chronic Respiratory Diseases Research Cenetr, Shahid Beheshti University of Medical Science, Tehran, Iran
Resident of Anesthesiology, Anesthesiology Research Cenetr, Shahid Beheshti University of Medical Science, Tehran, Iran
Journal of Cellular & Molecular Anesthesia: Vol.1, issue 4; e149520
published online: August 26, 2016
article type: Brief Communications
DOI: https://doi.org/10.22037/jcma.v1i4.13467

how to cite: jahangirifard A, Golestani Eraghi M, Saghafi M A. Heparin- induced thrombocytopenia (HIT): a case report of CABG patient. J Cell Mol Anesth. 2016;1(4):e149520. https://doi.org/10.22037/jcma.v1i4.13467.

Abstract

Heparin- induced thrombocytopenia (HIT) is an antibody mediated adverse effect of heparin therapy which is classified into two subtypes, HITI which is non-immune, spontaneously reversible thrombocytopenia and; HITII which is an autoimmune-mediated adverse effect of heparin therapy. In this case report, we described a 65-year old male patient with HITII after coronary artery bypass grafting.Key words: Heparin- induced thrombocytopenia, Heparin- induced thrombosis, coronary artery bypass grafting.

References

  • 1.

    References are in the PDF file of the article.